Wyoming is currently home to 65 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including Sheridan, Cody, Casper and Cheyenne. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
Sustaining Physical Activity After Cancer Exercise Sessions
NCT06359210
Recruiting
The goal of this clinical trial is to develop and test an adaptive physical activity (PA) maintenance intervention for cancer survivors, after participating in a community-based exercise oncology program. The main questions it aims to answer are: Aim 1: Examine the feasibility and acceptability of the intervention among cancer survivors and community partners. The researchers will utilize quantitative surveys, focus groups, and semi-structured interviews to collect information about feasibility... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
04/05/2024
Locations: University of Wyoming, Laramie, Wyoming
Conditions: Exercise Oncology, Physical Activity Behavior, Behavior Change Interventions
Register for Updates
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
NCT03723928
Recruiting
This randomized research trial studies how well serum tumor marker directed disease monitoring works in monitoring patients with hormone receptor positive Her2 negative breast cancer that has spread to other places in the body. Using markers to prompt when scans should be ordered may be as good as the usual approach to monitoring disease.
Gender:
All
Ages:
18 years and above
Trial Updated:
04/03/2024
Locations: Cheyenne Regional Medical Center-West, Cheyenne, Wyoming
Conditions: Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive, HER2/Neu Negative, Progesterone Receptor Positive, Prognostic Stage IV Breast Cancer AJCC v8, Elevated CA15-3 or CEA or CA27-29
Register for Updates
Evaluation of Body Composition Improvement With Visceral Adiposity-Focused Anti-Obesity Telehealth Program
NCT05219240
Recruiting
A retrospective review of body composition changes in patients who participate in a 9-week non-invasive intensive health care provider supervised weight loss program as an overall cohort and in sub-cohorts of interest.
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
12/18/2022
Locations: 20Lighter Telehealth Program, Cheyenne, Wyoming
Conditions: Obesity, Cardiovascular Diseases, Metabolic Syndrome, Metabolic Disease
Register for Updates
Navigation and Parent Peer Support to Promote Access
NCT04029220
Recruiting
Nearly one in five children in the United States has a mental health problem that interferes with daily functioning and requires intervention, and yet less than 50% of children who need mental health care receive any services. Families and especially from low-income and ethnically diverse backgrounds, experience a range of barriers to engaging in services for their children including: lack of recognition of problems and knowledge of available treatments, connecting to services, trust in provider... Read More
Gender:
All
Ages:
Between 1 year and 99 years
Trial Updated:
08/15/2022
Locations: Uplift Wyoming, Cheyenne, Wyoming
Conditions: Mental Disorder, Child, Mental Health, Family Health
Register for Updates
Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
NCT05401357
Recruiting
This is a randomized, double-blind, two-treatment, single-period, parallel design, multiple dose at multiple clinical trial sites designed to demonstrate bioequivalence with clinical endpoint in subjects with chronic open-angle glaucoma or ocular hypertension in both eyes. Test Product - Bimatoprost ophthalmic solution, 0.01% of Amneal EU, Limited Reference Product - LUMIGAN® (bimatoprost ophthalmic solution) 0.01% of Allergan, Inc.
Gender:
All
Ages:
18 years and above
Trial Updated:
08/09/2022
Locations: Cheyenne Eye Clinic & Surgery Center, Cheyenne, Wyoming
Conditions: Glaucoma, Open-Angle, Ocular Hypertension
Register for Updates